Clinical trial
Effect of Different Doses of Salacinol Extract on Glycemic and Insulinemic…
NCT00306072 · Ross Products, Industry · Completed
Key facts
| NCT number | NCT00306072 |
|---|---|
| Title | Effect of Different Doses of Salacinol Extract on Glycemic and Insulinemic Response in Patients With Type 2 Diabetes |
| Official title | Effect of Different Doses of Salacinol Extract on Glycemic and Insulinemic Response in Patients With Type 2 Diabetes |
| Lead sponsor | Ross Products, Industry |
| Status | Completed |
| Phase | Phase 1/Phase 2 |
| Study type | Interventional |
| Conditions | Diabetes Mellitus |
| Intervention type | Drug |
| Interventions | nutritional herbal extract from Salacia oblonga |
| Enrollment | 82 |
| Start date | Jun 1, 2005 |
| Completion | Sep 1, 2005 |
| First posted | Mar 22, 2006 |
| Last update posted | Jan 27, 2010 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: